ADAGIO MEDICAL HOLDINGS, INC. Share-based Payment Arrangement, Expense
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Share-based Payment Arrangement, Expense of $479.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $479.00K, a 104.70% increase year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $389.00K, a 78.44% increase year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $890.00K.
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $137.00K.
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2025 was $1.48M.
- ADAGIO MEDICAL HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2023 was $442.00K.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 7 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479.00K 10-Q · filed 2026-08-11 | $868.00K 10-Q · filed 2026-08-11 | $1.76M derived: sum of 3 quarters · filed 2026-08-11 | $1.90M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $389.00K 10-Q · filed 2026-05-12 | $1.28M derived: sum of 2 quarters · filed 2026-05-12 | $1.42M derived: sum of 3 quarters · filed 2026-05-12 | $1.65M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.03M derived: sum of 2 quarters · filed 2026-03-27 | $1.26M derived: sum of 3 quarters · filed 2026-08-11 | $1.48M 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $137.00K 10-Q · filed 2025-11-12 | $371.00K derived: sum of 2 quarters · filed 2026-08-11 | $589.00K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $234.00K 10-Q · filed 2026-08-11 | $452.00K 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | $218.00K 10-Q · filed 2026-05-12 | |||||
| 2024-07-30 | $421.00K 10-Q · filed 2025-11-12 | $642.00K 10-K · filed 2026-03-27 | ||||
| 2024-06-30 | $111.00K 10-Q · filed 2025-08-14 | $221.00K 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $110.00K 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | $442.00K 10-K · filed 2025-03-27 | |||||
| 2023-07-30 | $126.00K 10-Q · filed 2024-11-14 | $329.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |